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Background. Postdiarrheal hemolytic uremic syndrome (HUS) is the most common cause of acute kidney
failure among US children. The Foodborne Diseases Active Surveillance Network (FoodNet) conducts population-
based surveillance of pediatric HUS to measure the incidence of disease and to validate surveillance trends in
associated Shiga toxin–producing Escherichia coli (STEC) O157 infection.
Methods. We report the incidence of pediatric HUS, which is deﬁned as HUS in children ,18 years. We
compare the results from provider-based surveillance and hospital discharge data review and examine the impact of
different case deﬁnitions on the ﬁndings of the surveillance system.
Results. During 2000–2007, 627 pediatric HUS cases were reported. Fifty-two percent of cases were classiﬁed as
conﬁrmed (diarrhea, anemia, microangiopathic changes, low platelet count, and acute renal impairment). The
average annual crude incidence rate for all reported cases of pediatric HUS was 0.78 per 100 000 children ,18 years.
Regardless of the case deﬁnition used, the year-to-year pattern of incidence appeared similar. More cases were
captured by provider-based surveillance (76%) than by hospital discharge data review (68%); only 49% were
identiﬁed by both methods.
Conclusions. The overall incidence of pediatric HUS was affected by key characteristics of the surveillance
system, including the method of ascertainment and the case deﬁnitions. However, year-to-year patterns were similar
for all methods examined, suggesting that several approaches to HUS surveillance can be used to track trends.
Hemolytic uremic syndrome (HUS) is a severe sequela
of Shiga toxin–producing Escherichia coli (STEC) O157
infection characterized by hemolytic anemia, thrombo-
cytopenia, and kidney failure. More than 90% of HUS
cases follow a diarrheal illness and most are attributable
to STEC O157 infection [1]. HUS is the most common
cause of acute renal failure among US children ,5y e a r s
of age [2, 3]; of the estimated 93 000 domestically ac-
quired STEC O157 infections in the United States each
year [4], approximately 6% will develop HUS [2]. The
mortality rate is approximately 5% [2]. HUS may result
in major long-term complications, including chronic
renal failure, neurologic dysfunction, and hyperten-
sion [5]. Providing appropriate supportive care in
at i m e l ym a n n e ri m p r o v e so u t c o m e s[ 6].
Surveillance for HUS provides a way to monitor
trends in STEC O157 infections, can help to assess
which strains of STEC are associated with severe out-
comes, and can evaluate whether improvements in
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STEC O157 infections can be inﬂuenced by changes in di-
agnostic practices. By providing a stable marker of STEC
incidence, HUS surveillance can be used to determine the
effectiveness of preventive measures. HUS surveillance is
complicated by the lack of a single diagnostic test and the
need for multiple data elements to validate each reported
case. The signiﬁcance of HUS as a public health issue was
reﬂected in the Healthy People 2010 goal to reduce the in-
cidence of postdiarrheal HUS among children ,5y e a r so f
age by 50% (to 0.9 cases per 100 000) [7]. The Foodborne
Diseases Active Surveillance Network (FoodNet) conducts
active surveillance for HUS in children ,18 years using 2
complementary case ascertainment methods. We compare
the ﬁnding of these 2 methods of case ascertainment and the
impact of different case deﬁnitions on surveillance data from
2000 to 2007.
METHODS
FoodNet is a collaborative program among the Centers for
Disease Control and Prevention, 10 participating state health
departments, the US Department of Agriculture’s Food
Safety and Inspection Service, and the US Food and Drug
Administration. FoodNet began in 1996 with 5 sites (California,
Connecticut, Georgia, Minnesota, and Oregon) and by 2004
had grown to 10 sites (with the addition of Colorado,
Maryland, New Mexico, New York, and Tennessee). Food-
Net sites conduct active, population-based surveillance for
pediatric HUS (HUS in children ,18 years of age) among
residents of the FoodNet catchment areas. Until 2007, cases
of HUS without a history of diarrhea preceding the illness
were also included in surveillance. Cases of thrombotic
thrombocytopenic purpura (TTP) were also included be-
cause TTP diagnosed after a diarrheal illness is usually
caused by infection with STEC O157 or another STEC, and
thus likely represents HUS [8].
Case Finding
Cases of HUS among residents of the FoodNet catchment
area were ascertained in 2 ways. First, FoodNet personnel
routinely contacted an established network of pediatric
nephrologists and hospital infection control practitioners to
identify patients with a physician diagnosis of HUS (provider-
based surveillance). Second, FoodNet sites conducted periodic
reviews of hospital discharge data (HDD) to supplement case
ﬁnding. HDD review was implemented in 2004 and was
conducted retrospectively to identify HUS cases occurring
since 2000 that may have been missed by the ﬁrst method. All
FoodNet sites conducted HDD reviews, with the exception of
New Mexico. Possible cases were identiﬁed from hospital
records by International Classiﬁcation of Diseases, Ninth
Revision, Clinical Modiﬁcation (ICD-9-CM) codes: 283.1
(hemolytic uremic syndrome); 584.X, 283.X, and 287.X
(acute renal failure with hemolytic anemia and thrombocy-
topenia); and 446.6 and 008.X, or 446.6 and 009.X (TTP with
diarrhea caused by E. coli or an unknown pathogen) [9].
FoodNet personnel obtained lists of patients with the spec-
iﬁed ICD-9-CM codes after annual hospital discharge data
were available at each hospital within their site. Medical
record reviews were performed for all possible cases that
were not previously reported through provider-based
surveillance.
A standard case report form was used to collect infor-
mation for all persons with HUS, including demographics
(age, race, sex), dates of hospitalization, month of specimen
collection, antimicrobial use, results of laboratory tests for
STEC and other pathogens, outcome, date of HUS diagnosis,
and date of entry into the FoodNet surveillance system.
Case Definitions
We classiﬁed cases as conﬁrmed, probable, and suspected.
Conﬁrmed cases met all of the following 5 criteria: (1) diarrhea
with onset in the 3 weeks before HUS or TTP diagnosis;
(2) anemia [10, 11]; (3) microangiopathic changes consistent
with hemolysis on peripheral blood smear (eg, schistocytes or
helmet cells); (4) platelet count ,150 000 platelets/mL;
and (5) acute renal impairment (age #12 years: creatinine
$1 mg/dL; age $13: creatinine $1.5 mg/dL) [12]. Cases that
met all criteria except documented microangiopathic changes
were considered probable cases. All other illnesses diagnosed by
a physician as HUS were considered suspected cases.
Analysis
We calculated crude incidence rates per 100 000 persons,
overall and by site and age, from 2000 to 2007, using pop-
ulation estimates from the US Census Bureau [13]. We
s u m m a r i z e dt h ec r u d ei n c i d e n c er a t eb yc a s ed e ﬁ n i t i o na n d
method of ascertainment (provider-based surveillance, HDD
review, or both). Cases were excluded from analyses by
method of ascertainment in instances where the method of
ascertainment was not recorded. We calculated the time that
elapsed between the date of HUS diagnosis and the date the
case was entered into FoodNet HUS surveillance. We cal-
culated season by the month of HUS diagnosis, where June–
August was classiﬁed as summer, September–November was
classiﬁed as fall, December–February was classiﬁed as winter,
and March–May was classiﬁed as spring. We summarized the
proportion of patient demographics, illness severity, and
laboratory ﬁndings for each case deﬁnition and method of
ascertainment. We used a v
2 test to determine if there was
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deﬁnition and the method of ascertainment for each char-
acteristic. The analysis was conducted using SAS software
version 9.1.3 (SAS Institute, Cary, North Carolina).
RESULTS
A total of 627 physician-diagnosed pediatric HUS cases were
reported to the FoodNet HUS surveillance system during
2000–2007. An average of 78 cases was reported each year
(range, 54–110). Most cases (66%; 416) were in children
,5 years old; of these, 64% were in children ,2y e a r so l d .
Fifty-six percent (350) were female. The overall incidence
rate was 0.78 per 100 000 children. Incidence was highest
in children ,5 years old (1.9 per 100 000 persons). The
highest incidence rates were in Oregon (1.3), Minnesota
(1.1), and Tennessee (1.0); the lowest rates were in Georgia
and Maryland (0.4).
Of all reported cases, 326 (52%) were classiﬁed as con-
ﬁrmed, 53 (8%) as probable, and 248 (40%) as suspected
(Table 1). Conﬁrmed, probable, and suspected cases were
reported every year. The proportion of cases classiﬁed as
conﬁrmed in each site ranged from 40% to 67%, the pro-
portion of cases classiﬁed as probable ranged from 3% to
30%, and the proportion classiﬁed as suspected ranged from
29% to 49%. Among the 248 suspected cases, evidence of
microangiopathic changes was the criterion most commonly
not met or missing (50% not met, 5% missing), followed by
evidence of renal injury, (37% not met, 9% missing), or
anemia (31% not met, 8% missing). Sixty-nine (28%) sus-
pected cases did not report diarrhea in the 3 weeks before
HUS diagnosis and an additional 5 were missing information
on this criterion. Among suspected cases, there were 176
(71%) with 1 criterion not met or missing, 49 (20%) with
2 criteria not met or missing, 2 (8%) with 3 criteria not met
or missing, and 3 (1%) with 4 criteria not met or missing.
We compared the crude incidence rates by year for con-
ﬁ r m e dc a s e s ,c o n ﬁ r m e da n dp r o b a b l ec a s e s ,a n dc o n ﬁ r m e d ,
probable, and suspected cases (Figure 1A). Regardless of the
case deﬁnition used, the year-to-year pattern of incidence
appeared similar. When both conﬁrmed and probable cases
were included, the annual incidence rate was an average of
16% (range, ,1%–32%) higher than the rate when only
conﬁrmed cases were used. However, the annual incidence
rate when all cases (conﬁrmed, probable, and suspected)
were included was an average of 92% (range, 81%–119%)
higher than the rate calculated with only conﬁrmed cases.
Inclusion of both probable and suspected cases did not
changethe rank order of incidence among sites or in children
,5y e a r s .
Two FoodNet sites (Connecticut and Minnesota) had state
restrictions to medical record access that limited their ability
to conduct HDD review, and therefore, 123 (20%) cases were
excluded from our comparison of ascertainment methods.
Among the 504 cases for which a method of ascertainment
was veriﬁed, 76% were captured by provider-based surveil-
lance and 68% were captured by HDD review (Figure 2).
Two hundred forty-nine (49%) were identiﬁed independently
by both provider-based surveillance and HDD review, 136
(27%) were found only by provider-based surveillance, and 96
(19%) were found only by HDD review (Figure 2). An ad-
ditional 23 cases were found by other means (ie, during an
outbreak or during routine STEC surveillance). The propor-
tion of cases identiﬁed by provider-based surveillance that
were conﬁrmed or probable (55%) was slightly higher than
the proportion identiﬁed by HDD review (49%), but this
difference was not statistically signiﬁcant (Table 1). At 4 sites
(Colorado, Georgia, Maryland, and New York), provider-based
surveillance identiﬁed a disproportionately greater number
of conﬁrmed and probable cases, while in one (Oregon),
HDD review identiﬁed more cases (Figure 3). The percentage
of cases found by both methods ranged from 19% in
Table 1. Number and Proportion of Hemolytic Uremic Syndrome Cases by Method of Ascertainment and Case Definition, FoodNet,
2000–2007
Method of Ascertainment
Provider-Based Hospital Discharge Data Review Other or Unknown
a All Cases
Case deﬁnition
Conﬁrmed 210 (55) 168 (49) 82 (56) 326 (52)
Probable 36 (9) 29 (8) 14 (10) 53 (8)
Suspected 139 (36) 148 (43) 50 (34) 248 (40)
Total 385 345 146 627
All data are presented as no. (%).
a The method of ascertainment could not be conﬁrmed for 123 cases. Twenty-three cases that were identiﬁed through other means (ie, outbreak, routine
surveillance for Shige toxin–producing Escherichia coli) were also reported.
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of cases captured by provider-based surveillance and HDD
review were compared, the year-to-year pattern appeared
similar from 2000 to 2006. In 2007, there was a higher rate
among cases captured by HDD review than provider-based
surveillance (Figure 1B).
Of the 615 reported HUS cases with complete information
on dates of illness onset and case ascertainment, the median
duration from the date of illness onset to the entry of data into
t h es u r v e i l l a n c es y s t e mw a s2m o n t h s .T h e r ew e r e4 7 0( 7 6 % )
cases entered into the system within 1 year of diagnosis and
535 (85%) within 2 years. Among cases with a veriﬁed method
of ascertainment, 79% of those identiﬁed by HDD review
were entered into the surveillance system within 2 years,
compared with 95% of those captured by provider-based
surveillance. Most (315, 82%) cases captured by provider-
based surveillance were entered into the HUS surveillance
system within 6 months of diagnosis.
We compared demographics, illness severity, and labora-
tory test ﬁndings by case deﬁnition and method of ascer-
tainment (Table 2). Compared with suspected cases, a higher
proportion of conﬁrmed cases were in children ,5y e a r so l d
(71% versus 59%, P , .01) and occurred in the summer
months (48% versus 33%, P , .01). Conﬁrmed cases were
Figure 1. A, Comparison of hemolytic uremic syndrome rates in children ,18 years old, by year and case definition, FoodNet, 2000–2007.
B, Comparison of hemolytic uremic syndrome rates in children ,18 years old, by year and method of ascertainment, FoodNet, 2000–2007.
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(57% versus 34%, P , .0001) and to have a stool specimen
obtained (97% versus 79%, P , .0001) or one cultured for
STEC O157 (93% versus 72%, P 5 .04). Cases identiﬁed by
provider-based surveillance were more likely than those iden-
tiﬁed by HDD review to occur during the summer months
(48% versus 41%, P 5 .04), to have had bloody diarrhea
(77% versus 66%, P , .01), to have any stool specimen obtained
(94% versus 87%, P , .01), and to have a stool specimen that
was tested for Shiga toxin (40% versus 31%, P , .01).
DISCUSSION
The ﬁndings of the FoodNet HUS surveillance system were
affected by key characteristics of the surveillance system,
including the methods for case ascertainment and classiﬁ-
cation. However, year-to-year patterns were similar for all
methods examined, suggesting that although the sensitivity
and speciﬁcity of the various approaches for HUS surveillance
vary, several methods can be used to track trends. For
FoodNet, a central goal of HUS surveillance is to provide
accurate information on trends over time to monitor prog-
ress toward meeting public health goals. Selection of the
optimal surveillance strategy for HUS depends on balancing
the best possible sensitivity and positive predictive value
with available resources. Becauses u r v e i l l a n c ef o rs y n d r o m e s
such as HUS is challenging because of the lack of a single
diagnostic test, detailed clinical and laboratory information
is needed to validate the reported diagnosis. Additionally,
the performance characteristics of the case deﬁnition will
vary based on the level of clinical and laboratory detail that
are available. Thus, it is important to evaluate the various
factors that affect the ﬁndings of the system by using dif-
ferent surveillance methods to ﬁnd cases.
The magnitude of the incidence rate reported by the
FoodNet HUS surveillance system varied by as much as 92%
depending on how cases were classiﬁed. Although all persons
with HUS were identiﬁed through a provider network or
were found using hospital discharge codes for HUS and re-
lated conditions, almost half were classiﬁed as suspected
Figure 2. Venn diagram illustrating the proportion of hemolytic uremic syndrome cases identified through provider-based surveillance and hospital
discharge data review, FoodNet, 2000–2007.
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nition, the interpretation of trends remained the same, sug-
gesting that the system would yield similar incidence patterns
independent of ascertainment methods or case deﬁnition. The
use of a more sensitive, less speciﬁc case deﬁnition for HUS
that did not require laboratory evidence of HUS likely led to
the inclusion of some persons without HUS, as well as many
with less severe HUS, as evidenced by the considerably lower
dialysis requirements of children meeting only the suspected
case deﬁnition. Conversely, the use of a less sensitive, more
speciﬁc case deﬁnition (conﬁrmed cases only) would likely
result in a failure to include some true HUS cases. All case
deﬁnitions showed similar changes in HUS rates at FoodNet
sites over time.
Provider-based surveillance was the more sensitive
method of case ascertainment, contributing 28% more cases
than HDD review alone. However, using HDD review to
supplement active surveillance increased the total number of
cases by 19%. In a perfect world, all cases of HUS would be
identiﬁed by both methods. However, we observed consid-
erable site-to-site variation in the proportion of cases found
by each method, illustrating potential gaps in surveillance
that require improvement. Using multiple methods of case
ascertainment periodically can also help to validate the ef-
fectiveness of surveillance.
Cases found by HDD review were less likely to be conﬁrmed
than those found by provider-based surveillance. This was
likely due, in part, to the use of broad discharge codes to
identify potential HUS cases for surveillance purposes. Be-
cause the FoodNet form did not collect information on the
speciﬁc codes that were used to identify each case, it was not
possible to look at the sensitivity of each code by the level of
case classiﬁcation. However, most of the other case charac-
teristics were similar, regardless of the mode of ascertain-
ment, suggesting that either method will capture a similar
cross-section of cases. Differences in the proportion of cases
where stool was tested for Shiga toxin indicate that providers
should be informedabouttheimportanceoftestingfor Shiga
toxin.
Several factors determine the optimal strategy for HUS
surveillance. While provider-based surveillance is timelier
than HDD review, extensive resources are necessary to es-
tablish and maintain relationships with healthcare providers.
Although less timely, HDD review can be a valuable sur-
veillance tool for illnesses that frequently result in hospi-
talization, are rare, or have severe outcomes [14–16]. HDD
review can be done only once annually, although issues of
restricted access to medical records can delay the process. In
the case of some FoodNet sites, this resulted in delays of
.2 years until a case was reported, or not having access to
the patient-level clinical data needed to conﬁrm the HUS
diagnosis because some sites were only allowed access to
aggregate data on HUS cases that were identiﬁed through
HDD review. These issues might make HDD review pro-
hibitive for other states that are considering strengthening or
expanding HUS surveillance.
Figure 3. Proportion of confirmed and probable hemolytic uremic syndrome cases ascertained by provider-based surveillance and hospital
discharge data review, by site, FoodNet, 2000–2007 (N 5 481). Categories are not mutually exclusive—cases could be identified by either or both
methods. Percentage of cases identifed by both methods: California, 80%; Colorado, 19%; Georgia, 25%; Maryland, 19%; New York, 82%; Oregon, 89%;
Tennessee, 64%. Three FoodNet sites (Connecticut, Minnesota, New Mexico) had state restrictions to medical record access that limited their ability
to conduct hospital discharge data review. Abbreviation: HUS, hemolytic uremic syndrome.
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techniques used by the FoodNet surveillance system, our
ﬁndings might not be comparable to other studies that
found cases of HUS using other case deﬁnitions [17–21].
Despite the use of 2 surveillance techniques, it is likely that
we missed cases and that other surveillance mechanisms
could further enhance case ﬁnding. At some sites, the ma-
jority of cases were identiﬁed by only one method, sug-
gesting that there may have been other cases that were
missed. Surveillance for HUS is challenging, ideally re-
quiring the use of multiple methods to detect trends over
time and ascertain all cases. Health departments should
consider available resources and data needs when choosing
the optimal surveillance strategy.
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